Corporate Publications

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America and the US. Our products are available in more than 100 countries. In 2021, Grünenthal employed around 4,500 people and achieved sales of € 1.5 bn.

Grünenthal Report 2021/22

2021 was another record year of double-digit growth for Grünenthal. Our great teamwork and our strong focus on patients kept our business moving forward – and opened up exciting opportunities to drive us closer to our vision of a world free of pain.
... Find out more

Responsibility Report 2021/2022

Our first Grünenthal Responsibility Report marks a milestone on our journey towards a fully integrated reporting of how we conduct our business responsibly and the impact we have on society and the environment. We report according to the Global Reporting Initiative (GRI) standards and subject our reporting to thorough external auditing.
... Find out more